Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mifobate (SR-202) 是一种有效且特异性的 PPARγ拮抗剂,可选择性抑制噻唑烷二酮 (TZD) 诱导的 PPARγ 转录活性,IC50为140 μM,具有抗肥胖和抗糖尿病作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 879 | 现货 | ||
5 mg | ¥ 2,450 | 现货 | ||
10 mg | ¥ 3,660 | 现货 | ||
25 mg | ¥ 5,880 | 现货 | ||
50 mg | ¥ 7,920 | 现货 | ||
100 mg | ¥ 10,600 | 现货 |
产品描述 | Mifobate (SR-202) is a potent and specific antagonist of PPARγ. Mifobate shows antiobesity, antidiabetic and antiatherosclerotic effects[1]. |
靶点活性 | PPARγ:140 μM (IC50) |
体外活性 | SR-202 is a new synthetic PPARgamma antagonist,, which inhibits both TZD-stimulated recruitment of the coactivator steroid receptor coactivator-1 and TZD-induced transcriptional activity of the receptor.?In cell culture, SR-202 efficiently antagonizes hormone- and TZD-induced adipocyte differentiation[1]. |
体内活性 | In vivo, decreasing PPARgamma activity, either by treatment with SR-202 or by invalidation of one allele of the PPARgamma gene, leads to a reduction of both high fat diet-induced adipocyte hypertrophy and insulin resistance.?These effects are accompanied by a smaller size of the adipocytes and a reduction of TNFalpha and leptin secretion.?Treatment with SR-202 also dramatically improves insulin sensitivity in the diabetic ob/ob mice[1]. |
别名 | SR-202, 米福贝特 |
分子量 | 358.65 |
分子式 | C11H17ClO7P2 |
CAS No. | 76541-72-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 35.87 mg/mL (100.01 mM), Sonication and heating are recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O | 1 mM | 2.7882 mL | 13.9412 mL | 27.8823 mL | 69.7058 mL |
5 mM | 0.5576 mL | 2.7882 mL | 5.5765 mL | 13.9412 mL | |
10 mM | 0.2788 mL | 1.3941 mL | 2.7882 mL | 6.9706 mL | |
20 mM | 0.1394 mL | 0.6971 mL | 1.3941 mL | 3.4853 mL | |
50 mM | 0.0558 mL | 0.2788 mL | 0.5576 mL | 1.3941 mL | |
100 mM | 0.0279 mL | 0.1394 mL | 0.2788 mL | 0.6971 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Mifobate 76541-72-5 DNA Damage/DNA Repair Metabolism PPAR diabetes Peroxisome proliferator-activated receptors adipocyte stimulation antiobesity transcriptional SR 202 type 2 obesity differentiation SR-202 米福贝特 SR202 activity selective antidiabetic inhibit Inhibitor inhibitor